Repeated Controlled Human Schistosoma Mansoni Infection

计划入组 24 人 · 首次发布于 2021 年 10 月 20 日

Schistosoma Mansoni in Mwanza Region, Tanzania

计划入组 37,500 人 · 首次发布于 2014 年 6 月 13 日

Clinical Evaluation of Ujiplus® Against Schistosoma Mansoni

计划入组 400 人 · 首次发布于 2020 年 12 月 22 日

Sm29 Protein

Fanconi Anemia (Prime Medicine)

Fanc-A gene therapy (Fanconi anemia)

MANCONI MAURO

Italy

MONSON BRIAN

United States

INSTITUTO MASSONE S.A.

Argentina

COVID-19 Vaccines Remain Effective Despite Helminth-Induced Immune Modulation, Preclinical Study Shows

Researchers Call for Urgent Integration of Female Genital Schistosomiasis Screening into HIV and Cervical Cancer Programmes

EMA Initiates Review of Rocket Pharma's Gene Therapy for Fanconi Anaemia